The Claim
GLP-1 drugs produce variable amounts of weight loss in humans.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
GLP-1 drugs cause different amounts of weight loss in different people.
See the scientific wording
GLP-1 drugs lead to variable weight loss in humans.
People's bodies respond differently to GLP-1 drugs because their nerve cells and fat cells have varying levels of GLP-1 receptors and how strongly those receptors activate signals that reduce hunger and increase calorie burning.
What the research says
3 studiesStudy: Weight-loss dynamics with tirzepatide versus semaglutide
Different people lose different amounts of weight on GLP-1 drugs—even when taking the same medicine. Some lose a lot, others lose very little, and this study shows that’s true for both tirzepatide and semaglutide.
This study shows that two similar weight-loss drugs don't work the same for everyone—one worked better than the other, which suggests people respond differently to GLP-1 drugs.
The study found that computers can predict very accurately who will lose a lot of weight on GLP-1 drugs and who won’t — meaning people respond very differently. This proves the drugs don’t work the same for everyone.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.